Valley Fever Diagnostic
Coccidioidomycosis (Valley Fever) dissemination
Research/DiscoveryActive
Key Facts
Indication
Coccidioidomycosis (Valley Fever) dissemination
Phase
Research/Discovery
Status
Active
Company
About RealSeq Biosciences
RealSeq Biosciences, founded in 2018 and based in San Diego, is pioneering the field of RNA fragmentomics to discover new biomarkers for advanced diagnostics. Its core technology, the RiboMarker® platform, combines a novel, low-bias library preparation method with NGS and AI-powered bioinformatics to analyze the >90% of cell-free RNA that current techniques cannot detect. The company is leveraging this platform to develop diagnostics, starting with a program for Valley Fever, while also generating revenue through the sale of sequencing kits and services to the research community. RealSeq is a privately held, NIH-funded company actively seeking research and industry collaborations.
View full company profile